|
US5552115A
(en)
*
|
1986-02-06 |
1996-09-03 |
Steris Corporation |
Microbial decontamination system with components porous to anti-microbial fluids
|
|
EP0533285A1
(en)
*
|
1991-09-17 |
1993-03-24 |
Rockwool/ Grodan B.V. |
Active drainage system
|
|
NL9400789A
(nl)
*
|
1994-05-11 |
1995-12-01 |
Rockwool Grodan Bv |
Drainagesysteem voor actieve en passieve vloeistofdrainage.
|
|
EP1157607A3
(en)
|
2000-05-26 |
2002-11-20 |
Hirose Co., Limited |
Method and apparatus for growing ornamental plants by hydroponic cultivation
|
|
GB0117183D0
(en)
*
|
2001-07-13 |
2001-09-05 |
Rockwool Int |
Method and apparatus for growing plants
|
|
GB0117182D0
(en)
*
|
2001-07-13 |
2001-09-05 |
Rockwool Int |
Method and system for growing plants
|
|
GB0300701D0
(en)
*
|
2003-01-13 |
2003-02-12 |
Rockwool Int |
Method and apparatus for growing plants
|
|
GB0409787D0
(en)
|
2004-04-30 |
2004-06-09 |
Rockwool Int |
Method and apparatus for growing plants
|
|
FR2870549B1
(fr)
*
|
2004-05-24 |
2006-08-25 |
Financ Elysees Balzac Sa |
Non-tisse recurant, outil d'entretien incorporant dans sa structure ledit non-tisse recurant, fabrication
|
|
EP2274425A2
(en)
|
2008-04-11 |
2011-01-19 |
Alnylam Pharmaceuticals Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
US8962580B2
(en)
|
2008-09-23 |
2015-02-24 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
CA2753975C
(en)
|
2009-03-02 |
2017-09-26 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
WO2011109427A2
(en)
|
2010-03-01 |
2011-09-09 |
Alnylam Pharmaceuticals, Inc. |
Improving the biological activity of sirna through modulation of its thermodynamic profile
|
|
WO2011133868A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
|
US10913767B2
(en)
|
2010-04-22 |
2021-02-09 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising acyclic and abasic nucleosides and analogs
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
CN120555426A
(zh)
|
2011-06-21 |
2025-08-29 |
阿尔尼拉姆医药品有限公司 |
血管生成素样3(ANGPTL3)iRNA组合物及其使用方法
|
|
LT3366775T
(lt)
|
2011-11-18 |
2022-08-10 |
Alnylam Pharmaceuticals, Inc. |
Modifikuoti rnri agentai
|
|
RU2678807C2
(ru)
|
2011-11-18 |
2019-02-01 |
Элнилэм Фармасьютикалз, Инк. |
СРЕДСТВА ДЛЯ РНКи, КОМПОЗИЦИИ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ТРАНСТИРЕТИНОМ (TTR)
|
|
US9856638B2
(en)
|
2012-01-30 |
2018-01-02 |
Rockwool International A/S |
Drain element
|
|
EP2880162B1
(en)
|
2012-08-03 |
2017-07-05 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
|
SMT201800039T1
(it)
|
2012-12-05 |
2018-03-08 |
Alnylam Pharmaceuticals Inc |
Composizioni di irna di pcsk9 e metodi di uso delle stesse
|
|
CN120574828A
(zh)
|
2013-03-14 |
2025-09-02 |
阿尔尼拉姆医药品有限公司 |
补体组分C5 iRNA组合物及其使用方法
|
|
PL2999785T3
(pl)
|
2013-05-22 |
2018-09-28 |
Alnylam Pharmaceuticals, Inc. |
Kompozycje iRNA Serpina1 i sposoby ich zastosowania
|
|
SG10202103166XA
(en)
|
2013-05-22 |
2021-04-29 |
Alnylam Pharmaceuticals Inc |
Tmprss6 irna compositions and methods of use thereof
|
|
US9402353B2
(en)
|
2013-06-10 |
2016-08-02 |
Waterpulse, Inc. |
Injector style irrigation system
|
|
TW201610151A
(zh)
|
2013-09-23 |
2016-03-16 |
阿尼拉製藥公司 |
治療或預防與甲狀腺素運載蛋白相關疾病之方法
|
|
WO2015106128A2
(en)
|
2014-01-09 |
2015-07-16 |
Alnylam Pharmaceuticals, Inc. |
MODIFIED RNAi AGENTS
|
|
CN106103718B
(zh)
|
2014-02-11 |
2021-04-02 |
阿尔尼拉姆医药品有限公司 |
己酮糖激酶(KHK)iRNA组合物及其使用方法
|
|
WO2015179724A1
(en)
|
2014-05-22 |
2015-11-26 |
Alnylam Pharmaceuticals, Inc. |
Angiotensinogen (agt) irna compositions and methods of use thereof
|
|
IL316808A
(en)
|
2014-08-20 |
2025-01-01 |
Alnylam Pharmaceuticals Inc |
Modified double-stranded RNA materials and their uses
|
|
EP3191591A1
(en)
|
2014-09-12 |
2017-07-19 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting complement component c5 and methods of use thereof
|
|
EP3207138B1
(en)
|
2014-10-17 |
2020-07-15 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
|
|
EP3904519A1
(en)
|
2014-10-30 |
2021-11-03 |
Genzyme Corporation |
Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
|
|
JP2017535552A
(ja)
|
2014-11-17 |
2017-11-30 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法
|
|
JP2018510621A
(ja)
|
2015-02-13 |
2018-04-19 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用方法
|
|
WO2016164746A1
(en)
|
2015-04-08 |
2016-10-13 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the lect2 gene
|
|
KR20250107273A
(ko)
|
2015-05-06 |
2025-07-11 |
알닐람 파마슈티칼스 인코포레이티드 |
인자 XII(하게만 인자)(F12), 칼리크레인 B, 혈장(플레처 인자) 1(KLKB1) 및 키니노겐 1(KNG1) iRNA 조성물 및 그의 이용 방법
|
|
WO2016201301A1
(en)
|
2015-06-12 |
2016-12-15 |
Alnylam Pharmaceuticals, Inc. |
Complement component c5 irna compositions and methods of use thereof
|
|
WO2016205323A1
(en)
|
2015-06-18 |
2016-12-22 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
|
|
WO2017048620A1
(en)
|
2015-09-14 |
2017-03-23 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
|
|
JP2018536689A
(ja)
|
2015-12-10 |
2018-12-13 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
ステロール調節エレメント結合タンパク質(SREBP)シャペロン(SCAP)iRNA組成物およびその使用方法
|
|
WO2017214518A1
(en)
|
2016-06-10 |
2017-12-14 |
Alnylam Pharmaceuticals, Inc. |
COMPLETMENT COMPONENT C5 iRNA COMPOSTIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
|
|
WO2020117840A2
(en)
|
2018-12-05 |
2020-06-11 |
Empirico Inc. |
Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions
|
|
USD872638S1
(en)
*
|
2019-07-04 |
2020-01-14 |
Deryck Yin |
Planter
|